Dudediligence.

Viatris Inc

VTRSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.74BSep ’24$3.52BDec ’24$3.24BMar ’25$3.57BJun ’25$3.75BSep ’25$3.69BDec ’25$3.51BMar ’26$3.75BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$17.81B$16.22B$15.39B$14.69B$14.25B
Gross profit$5.58B$6.50B$6.44B$5.62B$5.01B
Operating income−$34.0M$1.61B$766.2M$10.1M−$2.66B
Net income−$1.27B$2.08B$54.7M−$634.2M−$3.51B
Operating cash flow$3.02B$3.00B$2.90B$2.30B$2.32B
Free cash flow$2.56B$2.59B$2.52B$1.98B$1.94B
Cash$701.2M$1.26B$991.9M$734.8M$1.32B
Debt$21.59B$19.27B$18.13B$14.05B$14.41B
Shares outstanding1.21B1.22B1.21Bnone on filenone on file